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Abstract
Background: A noninvasive system for determining left ventricular (LV) filling pressure may help to improve personalized
fluid removal goals in hemodialysis patients. We previously showed that the change in photoplethysmography (PPG)
pulse amplitude measured by finger PPG during a Valsalva maneuver correlates with invasively measured left ventricular
end-diastolic pressure (LVEDP). This key PPG change, the ratio of finger PPG pulse amplitude at end-Valsalva to baseline, is
known as the Pulse Amplitude Ratio, PAR. The objective of this study was to determine how PAR changes after fluid
removal in hemodialysis.
Methods: We tested subjects with end-stage renal disease, before and after hemodialysis. Each subject performed a
Valsalva maneuver with an effort of 20 mmHg for 10 s, guided by the device display. Finger PPG was recorded
continuously before and during the maneuver. PAR was calculated automatically.
Results: Twenty-seven subjects (21 Males) ages 25–75 years were tested. Access sites were AV-fistulas of the arm
predominantly. Weight decreased from 99.7 ± 36.9 kg to 97.0 ± 36.0 kg (p < 0.0003) with an average fluid removal
of 3.07 ± 1.08 l. Correspondingly, PAR decreased from 0.74 ± 0.24 to 0.62 ± 0.23 (p = 0.003). The change in PAR was
correlated with baseline PAR (r = 0.48, p = 0.01).
Conclusion: An index of left heart filling pressure obtained noninvasively using finger photoplethysmography
during the Valsalva maneuver is sensitive enough to detect reductions in filling pressure after fluid removal with
hemodialysis. Further studies are warranted to determine if this method can be used to guide fluid removal
during hemodialysis.
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Background
Hemodialysis patients undergo volume shifts during
their dialysis in an attempt to reach optimal dry weight.
The significance of dry weight achievement lies in that
fluid accumulation between dialysis has been demon-
strated to be a predictor of death and cardiovascular
complications [1]. Aiming to achieve ideal dry weight is
hindered by the need to tailor volume subtraction to the
hemodynamic tolerance of a patient [2, 3]. Patients with
left ventricular dysfunction may be even more susceptible
to poor outcomes if hemodialysis fails to remove an ad-
equate fluid amount [4]. Further, intradialytic hypotension
continues to be a frequent complication in hemodialysis
patients, and is also associated with increased morbidity
and mortality [5, 6]. Many tools have been investigated for
assessing volume status in hemodialysis patients, including
standard echocardiography for Doppler indices of that are
related to filling pressure [7], hand-carried ultrasound as-
sessment of IVC [8], chest ultrasound to assess lung water
[9], serum proBNP [7], central venous oxygenation [10],
and bioimpedance [11]. However, no one test has a com-
bination of being noninvasive, convenient, inexpensive,
point-of-care, and immediate, and sensitive and specific
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enough to determine optimal individual volume removal.
Left ventricular filling pressure is a direct hemodynamic
determinant of left ventricular strain and of systemic
hypotension. Therefore, a noninvasive system for deter-
mining left ventricular filling pressure could help to im-
prove personalized fluid removal goals in hemodialysis
patients.
Assessing cardiac filling pressure clinically is challen-
ging, especially with current non-invasive strategies (e.g.
physical exam, blood markers), since many tests are nei-
ther sensitive nor specific [12]. The Valsalva maneuver,
defined as a sustained straining against a closed upper
airway, has shown utility in assessing volume status
and cardiac hemodynamic properties [13–16]. Yet, the
Valsalva maneuver remains underutilized clinically,
likely due to the inability to standardize the expiratory
effort and the difficulties obtaining a continuous nonin-
vasive surrogate of a pressure waveform conveniently
[16]. Finger photoplethysmography conveniently pro-
vides a continuous pressure surrogate waveform during
the Valsalva maneuver. We have shown that the pulse
amplitude response of a finger photoplethysmography
waveform correlates well with invasively measured left
ventricular end-diastolic pressure (LVEDP) [17].
Recently, we have developed a hand-held, battery-
powered device that guides patients in performing a
Valsalva maneuver at 20 mmHg expiratory effort for
10 s while recording finger photoplethysmography. It
automatically calculates pulse amplitude ratio (PAR),
the amplitude at end-Valsalva divided by the amplitude
at baseline. The objective of this study was to deter-
mine if PAR is sensitive enough to detect changes in
left heart filling pressure that accompany fluid removal
in hemodialysis.
Methods
Participants were recruited from Johns Hopkins Bayview
Medical Center and DaVita J.B. Zachary Dialysis Center
from February 2012 to July 2013. Eligible patients included
those between the age of 20–85 years who are receiving
chronic, intermittent hemodialysis as an inpatient at Johns
Hopkins Bayview Medical Center or outpatient at DaVita
J.B. Zachary Dialysis. Patients were excluded if they had
acute onset of renal failure with less than three dialysis
sessions during their inpatient stay, if an inpatient
required dialysis at the bedside, patients in the inten-
sive care unit, and patients unable or unwilling to per-
form a Valsalva maneuver. All participants provided
written informed consent. The procedures followed
were in accordance with the ethical standards of the
Helsinki Declaration of 1975, as revised in 2000, and
the Johns Hopkins University Institutional Review
Board reviewed and approved the protocol.
Participants were tested while in a seated position
(outpatient) or in a semi-recumbent position (inpatient),
within 15 min prior to their hemodialysis session and
again 15 min after their hemodialysis session was com-
pleted. The device’s photoplethysmography transducer
was attached to either their middle or ring finger on the
hand opposite of the hemodialysis access site. For ex-
ample, if the subject had an arterio-venous (AV) fistula
in their right upper extremity, the photoplethysmogra-
phy transducer was used on the left middle or ring fin-
ger (belonging to the extremity without the AV fistula);
if the patient had a left subclavian catheter, the right
hand was used. A mouthpiece attached to a pressure
transducer input into the device was given to the partici-
pant to hold in the contralateral hand. Participants were
coached using a graphical user interface on the screen of
the device. The screen displayed the expiratory pressure
signal, and provided upper and lower limits for the par-
ticipant to maintain an exhalation effort of 20 mmHg
for 10 s. The pressure and photoplethysmography
signals were recorded simultaneously. A minimum of
three and a maximum of six successful expiratory ef-
forts were acquired.
The patient had the same coach before and after
hemodialysis. All coaches were trained and had demon-
strated the ability to adequately teach participants prior
to enrolling formal subjects. Further, the device’s design
allows for standardization of the Valsalva performance;
therefore, minimizing inter-observer error.
“Years of hemodialysis” was defined as years requiring
hemodialysis without discontinuation. For example, if a
subject was on hemodialysis in the past and had stopped
(e.g. due to a renal transplant or a switch to peritoneal dia-
lysis), then restarted, the time of restarting to the time of
recruitment was defined as “years of hemodialysis”.
Only five subjects had prior hemodialysis that was dis-
continued (either due to a kidney transplant or prior
peritoneal).
Transduced signals were input into the device. Filter-
ing parameters of the photoplethysmography signal were
10-Hz low pass and 0.01-Hz high pass. An exhalation ef-
fort achieved within 3 s and sustained between 18 and
25 mmHg for 10 s was required in order for the device
to record the data. If three successful attempts could not
be achieved, whether before or after hemodialysis, the
subject was documented as “unable to complete”; any
data obtained from such a subject was not used towards
analysis. Waveforms were analyzed using software ac-
companying the digital acquisition system. For each
Valsalva effort, the amplitudes of three typical cycles of
the baseline photoplethysmography waveform were aver-
aged. The amplitude of the cycle just before 10 s into
the Valsalva maneuver was measured. We did not use
multiple cycles when calculating pulse amplitude during
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the Valsalva maneuver because the amplitude changes
continuously during the maneuver. The average PAR
over all the acceptable efforts was obtained before
hemodialysis and again after hemodialysis.
All values are reported as mean ± standard deviation
unless otherwise specified. We examined the distribution
of variables and change in variables by assessing sym-
metry of box plots. We did not opt to formally test the
normality of these variables because of the expected low
statistical power of such a test with the sample size we
have. We would not have been able to determine whether
a non-significant p-value really meant normality or was
due to larger than desired type two error. Coefficient of
variation was calculated for each set of baseline PAR mea-
surements as standard deviation / mean. The average coef-
ficient of variation was calculated over all the subjects
tested. Statistical comparisons between pre-dialysis and
post-dialysis variables were performed using paired t tests.
Relationships between PAR and other variables were
ascertained using simple linear regression. Analyses were
conducted with SigmaPlot 11.0 (San Jose, CA).
Results
A total of 29 subjects were recruited between the two
sites; however, 2 of the subjects could not complete the
required number of successful Valsalva maneuvers and
were excluded from the final analysis. Therefore, 27
subjects, of which 6 were female, were reviewed and
their data is presented below. The mean age was 53.2 ±
13.4 years, with the range being between 25 to 75 years.
Table 1 lists the characteristics of the participants,
along with the absolute number of and the percent of
participants with that characteristic. The most common
comorbidity among the subjects was hypertension
(78 %) and all hypertensive subjects were on antihyper-
tensive medications.
With regard to the renal characteristics of the subjects
(Table 1), the median duration of ESRD treated with
hemodialysis was 1.5 years (range 6 months to 5.25 years).
The majority of the subjects (78 %) said they could still
make urine. The mean ultrafiltration rate was 1.60 ±
0.29 L/h. As for access sites, 21 subjects had arterio-
venous fistulas that were being used. Only one subject did
not finish the desired preset hemodialysis time, finishing
30 min early due to cramps; however, the subject was still
able to perform an expiratory effort within 15 min of dis-
continuing hemodialysis.
Figure 1 shows an example of simultaneously recorded
photoplethysmography and expiratory pressure effort
waveforms. Also shown is how PAR is obtained.
Table 2 shows the changes in variables before and after
hemodialysis. All continuous variables with normal dis-
tributions are presented as mean ± standard deviation.
The average coefficient of variation was 0.14. Figure 2
shows a Bland-Altman plot of the first and last baseline
PAR measurements in each subject.
There was a statistically significant change in diastolic
blood pressure before and after hemodialysis (79.8 ±
14.9 mmHg to 72.6 ± 13.6 mmHg, p = 0.003); however, no
other vital signs changes were statistically significant.
Weight and body mass index changes did have significant
changes as well (99.7 ± 36.9 kg to 97.0 ± 36.0, p < 0.0003;
35.2 ± 13.7 kg/m2 to 34.3 ± 13.4 kg/m2, p < 0.0004, respect-
ively). The mean volume removed was 3.07 ± 1.08 L, with
a range of 0.6 L to 5.0 L. Correspondingly, there was a sig-
nificant decrease in PAR, from 0.74 ± 0.24 to 0.62 ± 0.23
(p = 0.003, Fig. 3). Furthermore, the change in PAR was
correlated with baseline PAR (r = 0.48, p = 0.01). The
Table 1 Subject characteristics
Number of subjects 27
Age (yr, ± S.D.) 53.2 ± 13.4
Gender (male) 21
Comorbidities
Hypertension (%) 21 (78)
Diabetes type 2 (%) 11 (41)
Congestive Heart Failure (%) 6 (22)
Chronic obstructive pulmonary disease (%) 4 (15)
Peripheral Arterial Disease (%) 0 (0)
Coronary Artery Disease (%) 14 (52)
Cirrhosis (%) 1 (4)
Medications
Calcium Channel Blockers (%) 16 (59)
β-Blocker (%) 20 (74)
Angiotensin-converting enzyme inhibitor (%) 9 (33)
Angiotensin receptor blocker (%) 2 (7)
Nitrate (%) 2 (7)
Thiazide Diuretic (%) 1 (4)
Loop Diuretic (%) 6 (22)
Clonidine (%) 2 (7)
Hydralazine (%) 4 (15)
Active smokers (%) 3 (11)
Years of hemodialysis (median) 1.5
Access site for hemodialysis
Catheter (Subclavian) (%) 5 (19)
Catheter (Internal Jugular) (%) 1 (4)
Arterio-venous fistula
Right Upper Extremity (%) 10 (37)
Left Upper Extremity (%) 11 (41)
Able to make any urine (%) 21 (78)
S.D. standard deviation, Co-Morbidities, Medications, Smokers, and Access site
for hemodialysis are presented as absolute number of subjects followed by %
of subjects in parentheses
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change in PAR was not correlated with volume removed
(r = 0.14, p = 0.33), volume removed per starting weight
(r = 0.11, p = 0.60), change in weight (r = 0.17, p = 0.39), or
relative change in weight (r = 0.12, p = 0.54). Also, the per-
cent change in PAR was not correlated with volume re-
moved (r = 0.07, p = 0.74), volume removed per starting
weight (r = 0.12, p = 0.55), change in weight (r = 0.12,
p = 0.53, or relative change in weight (r = 0.13, p = 0.51).
One patient with 3 years of hemodialysis requirement
experienced significant muscle cramps, requiring hemo
dialysis to be discontinued 30 min before desired com-
pletion (targeted hemodialysis time 240 min; actual was
180 min). The patient’s weight decreased by 4.7 kg
(179.6 kg to 174.9 kg) with a change in PAR 0.06. There
was a fall in both systolic and diastolic blood pressures
(from 137 to 108 mmHg systolic and from 75 to
55 mmHg diastolic). Heart rate did not change (93 beats
per minute to 86 beats per minute). Of note the patient
was on no anti-hypertensive medications.
Discussion
In this study, we investigated whether a noninvasive
index of left heart filling pressure using finger photo-
plethysmography during the Valsalva maneuver is sensi-
tive enough to detect changes that occur after one
session of hemodialysis. The index is the ratio of pulse
Fig. 1 A typical photoplethysmography (PPG) waveform response during the Valsava maneuver: a Before hemodialysis and b After hemodialysis.
Pulse amplitude ratio (PAR) is calculated as the pulse amplitude of the waveform at the end of 10 s of Valsalva (PAV) divided by the average
pulse amplitude of several cycles at baseline (PAB). In this example, PAR = 0.81 before hemodialysis and PAR = 0.67 after hemodialysis. The
automated algorithm acquiring the data allows a maximum of 3 s for the subject’s expiratory effort to equal or exceed 20 mmHg in order for the
data to be accepted and stored
Table 2 Characteristics before and after hemodialysis
Before After P, After vs
BeforeHemodialysis Hemodialysis
Systolic Blood Pressure (mmHg) 138.7 ± 19.4 133.2 ± 25.0 p = 0.081
Diastolic Blood Pressure (mmHg) 79.8 ± 14.9 72.6 ± 13.6 p = 0.003*
Heart rate (beats per minute) 82.2 ± 12.8 80.4 ± 11.2 p = 0.221
Temperature (Fahrenheit) 98.0 ± 0.72 98.0 ± 0.81 p = 0.481
Weight (kg) 99.7 ± 36.9 97.0 ± 36.0 p < 0.0003*
Body Mass Index (kg / m2) 35.2 ± 13.7 34.3 ± 13.4 p < 0.0004*
Volume Removed (L) ———— 3.07 ± 1.08
Duration of Hemodialysis (minutes) ———— 225.9 ± 31.6
Range (min) 180–330
Number of Successful Expiratory efforts 3.51 ± 0.71 3.82 ± 0.91 p = 0.152
Pulse Amplitude Ratio 0.74 ± 0.24 0.62 ± 0.23 p = 0.003*
Variables are presented as mean ± standard deviation. * p < 0.05 considered significant
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amplitude at end-Valsalva to pulse amplitude at rest
(Pulse Amplitude Ratio, PAR). We used a hand-held,
battery-powered device with an automated graphical
user interface that guides the subject and calculates
PAR. We found that PAR measured by the device does
change significantly with one session of hemodialysis.
The implication is that the change in left ventricular fill-
ing pressure that occurs with volume removal during
dialysis can be detected noninvasively. Therefore, it is
worth investigating whether PAR can be used to detect
residual left ventricular pressure overload between dialy-
sis sessions, or whether PAR can predict intradialytic
hypotension.
We also found that the change in PAR with
hemodialysis correlated with baseline PAR; i.e., when
pre-hemodialysis PAR was higher, the decrease in PAR
with hemodialysis was greater. This suggests that
when pre-hemodialysis LVEDP is higher, the decrease
in LVEDP with hemodialysis is greater. This probably
reflects the nonlinear pressure-volume relation in the
left ventricle, where a given change in volume pro-
duces a greater change in pressure at higher starting
points on the curve [18]. The correlation was not
strong, probably in part because the pressure-volume
curve is different for different subjects.
The change in PAR was not correlated with the amount
of volume removed or with the change in weight. This is
also probably due to the nonlinear pressure-volume rela-
tion. Each subject may have been on a different starting
point on their pressure-volume curve, and each subject’s
pressure-volume curve may differ from that of the others.
Hence, a given volume removed with HD cannot pre-
dict the magnitude of the resulting decrease in LVEDP.
This concept may help to explain some of the limita-
tions of using volume and weight changes to manage
dialysis patients.
Blood pressure responses to the Valsalva maneuver
and their correlation with cardiac volume or pressure
was first demonstrated several decades ago, and later by
others [13–15, 19, 20]. The Valsalva maneuver increases
intrathoracic pressure and with the transmission of the
elevated intrathoracic pressure to the periphery, one sees
a rise in blood pressure initially. If the maneuver is sus-
tained for at least 10 s, the limitation on venous return
will lead to a decrease in stroke volume, and thus, a
decrease in peripheral pulse amplitude [15]. However, if
the patient has elevated cardiac filling pressures due to
volume overload (e.g. underdialyzed end-stage renal dis-
ease, congestive heart failure), then the sustained expira-
tory effort will not result in a decrease in stroke volume
due to the reservoir of central blood volume [19, 20].
Therefore, in patients with end-stage renal disease on
chronic hemodialysis, quantifying these changes may be
useful in individualizing fluid removal goals.
PAR is a continuous variable, best measured using a
continuous waveform. PAR has been shown to reflect
left heart filling pressure using indwelling pressure trans-
ducers [15, 19] and noninvasive surrogates of a continu-
ous blood pressure waveform [21–23]. We demonstrated
the correlation between PAR and LVEDP using ordinary
finger photoplethysmography and an expiratory effort of
20 mmHg, which is a milder effort than is used in other
studies and can be achieved by more patients [17].
Other non-invasive techniques have been investigated
for assessing changes after hemodialysis fluid removal.
One technique is ultrasound Doppler imaging to evalu-
ate the ratio of early transmitral flow velocity (E) to early
Fig. 2 Bland-Altman plot of baseline Pulse Amplitude Ratio
(PAR) measurements
Fig. 3 Box plots of Pulse Amplitude Ratio (PAR) by finger
photoplethysmography (PPG), before and after hemodialysis. PAR
decreased after one session of dialysis
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diastolic mitral annular velocity (E’), because E/E’ has
been shown to reflect left ventricular filling pressure
[24, 25]. In a longitudinal study, E/E’, as well as serum
proBNP, increased over time, suggesting that these indi-
ces might be useful in managing hemodialysis goals in
order to limit chronic fluid overload [7]. However, echo-
cardiography and serum variables would be impractical
for assessing acute changes in hemodialysis patients.
Other limitations of using echo Doppler indices are the
cost of the machine and the need for a specialized
ultrasonographer.
Lung ultrasound to detect pulmonary congestion
(extravascular lung water) has been studied [9]. Lung
water (and thus lung congestion) was reduced after dia-
lysis but also could indicate residual congestion after
dialysis. However, it is unclear what was involved in
quantifying lung water. And, as with cardiac echocardi-
ography, a highly trained operator is required.
Hand-carried ultrasound (HCU) to assess IVC diam-
eter has been shown to predict patients who developed
intradialytic hypotension [8]. HCU is much less expen-
sive and more portable than standard echocardiography
machines. Also, although training is required for profi-
ciency in using HCU to assess IVC diameter, less train-
ing is required than to perform standard echocardio
graphy. However, a photoplethysmography-based hand-
held device would be much less expensive than HCU,
and an automated patient user-interface and PAR calcu-
lation algorithm allow for minimal operator training.
Central venous oxygen saturation (ScO2) from dialysis
catheters has shown promise in predicting intradialytic
hypotension during hemodialysis [10]. There was a wider
gap in ScO2 measurements between hypotension-prone
and hypotension-resistant patients than the gap in blood
volume measurements, the current standard tool for
intradialytic monitoring. However, as the authors point
out, the results are not generalizable to the dialysis
population, most of whom have A-V fistulas.
Basso et al. compared several techniques for assessing
the fluid status of chronic hemodialysis patients before
and after hemodialysis, including bioimpedance spec-
troscopy, ultrasound lung comet score, B-type natri-
uretic peptide (BNP), and IVC diameter [26]. Each
technique was able to detect changes in volume status
with dialysis. Also, each detected hyperhydration before
and after hemodialysis except for IVC diameter, and
each detected hypovolemia before and after hemodialysis
except for BNP. Interoperator reproducibility was high
for each technique. Although BIA devices provide infor-
mation about hydration status, extracellular water ex-
pansion as determined by BIA may not equate with
plasma volume expansion [11].
The use of PAR based on a noninvasive waveform dur-
ing the Valsalva maneuver was shown in one study to
yield prognostic information in hemodialysis patients
[4]. A noninvasive blood pressure waveform during the
Valsalva maneuver identified future heart failure exacer-
bation. The investigators used a Finapres, a sophisticated
and expensive device based on the volume clamp
method, which employs photoplethysmography in a
servo-controlled feedback of an inflatable finger cuff.
Whether PAR using ordinary finger photoplethysmogra-
phy has prognostic value in hemodialysis patients needs
further investigation.
Our study had several limitations. First, the number of
patients evaluated was relatively small, 27. Although a
statistically significant change in PAR was demonstrated,
a larger number of subjects will need to be studied to es-
tablish the utility of PAR by finger photoplethysmogra-
phy in guiding volume management in hemodialysis
patients. Second, we did not quantify the amount of
urine the recruited patients typically make in a day.
Third, although we have previously shown that PAR by
finger photoplethysmography correlates with invasively
measured LVEDP in patients undergoing a cardiac
catheterization for clinical reasons [Silber], we did not
invasively measure LVEDP in these dialysis patients.
Since hemodialysis patients may have calcification of
their vasculature, which may impact PAR values ob-
tained on distal extremities, it would be useful in a fu-
ture study to determine the PAR-LVEDP relation
specifically in a cohort of dialysis patients undergoing
clinical cardiac catheterization. Fourth, we did not inves-
tigate whether the type of hemodialysis access played a
role in PAR values obtained (e.g. comparing AV-fistulas
with catheters). Again, future studies with a larger popu-
lation will be needed to explore this further.
Conclusion
In conclusion, an index of left heart filling pressure (PAR)
obtained noninvasively using finger photoplethysmogra-
phy during the Valsalva maneuver is sensitive enough to
detect reductions in filling pressure after fluid removal
with hemodialysis. Further studies are warranted to de-
termine the clinical utility of PAR to help guide individ-
ualized goal-setting of fluid removal in dialysis.
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